HEARTBURN CANCER UK’s Post

As we observe Esophageal Cancer Awareness Month, the National Foundation for Cancer Research (NFCR) wishes to highlight the crucial role of awareness and early detection in combating esophageal cancer. This disease is one of the deadliest forms of cancer, largely due to its late diagnosis in many patients. In the United States, esophageal cancer is expected to result in approximately 22,370 new cases and cause nearly 16,130 deaths in 2024. This cancer type has a five-year survival rate of about 20%, underscoring the importance of recognizing symptoms early and undergoing regular medical screening. This April, let's raise our voices and spread the word about the significance of early detection and support the ongoing research that brings hope to those affected by esophageal cancer. https://lnkd.in/egA25rnh #esophagealcancerawareness #cancerresearch #earlydetection #NFCR #fightcancer #innovation #healthawareness #cancerprevention #savelives #makecurespossible

April is National Cancer Control Month, a time dedicated to raising awareness about cancer prevention, early detection, and research towards finding a cure. Research shows that up to 50% of cancer cases and about 50% of cancer deaths are preventable, with strategies focused on prevention, early detection, and effective treatments. In this National Cancer Control Month, we at the National Foundation for Cancer Research (NFCR) encourage you to take proactive steps in the fight against cancer. Here are ways you can contribute: 1. Educate yourself and others about cancer prevention and early detection 2. Advocate for policies supporting cancer research and patient care 3. Volunteer with organizations that support cancer patients and research 4. Donate to support groundbreaking cancer research This National Cancer Control Month, we're not just celebrating progress; we're accelerating it. Join NFCR in this mission and turn hope into action! Visit our website at www.nfcr.org to learn more about cancer and get involved in making cures possible! https://lnkd.in/egA25rnh #nationalcancercontrolmonth #cancermoonshot #makecurespossible #cancerresearch #collaboration #innovation #cancertreatment #cancersupport #NFCR 

Featured on the hub, a blog by Alfie Bailey-Bearfield from Pancreatic Cancer UK on the challenges associated with diagnosing pancreatic cancer & why fast and accurate diagnosis is so important: https://lnkd.in/emfM_xk3 November is Pancreatic Cancer Awareness Month. Pancreatic cancer is the deadliest common cancer, with more than half of people dying within three months of diagnosis. In contrast to many other cancers, people’s chances of surviving this disease haven’t improved in decades. You can find out more about Pancreatic Cancer UK's new campaign around this, 'More than hope', here: https://lnkd.in/eVn4ENdS Alfie's blog was originally published as part of a series for World Patient Safety Day 2024 and the theme of Improving diagnosis for patient safety. #PancreaticCancerAwarenessMonth #Pancreaticcancer #WPSD24 #WorldPatientSafetyDay2024 #diagnosticsafety Alfie B.

Today, on World Ovarian Cancer Day, we at the National Foundation for Cancer Research (NFCR) reflect on the significant challenges and opportunities in the fight against this 'silent killer. Only 1 in 5 patients with ovarian cancer receive a diagnosis in its earliest, most treatable stages. When caught in the early stages, the 5-year survival rate is 92%, which is incredibly promising. This World Ovarian Cancer Day, NFCR is dedicated to addressing the critical, unmet needs that exist in the early detection and treatment of ovarian cancer. We are committed to advancing research and innovations that aim to increase early diagnosis and improve the lives of patients. Join us in our commitment. Support NFCR to make cures possible for ALL and bring hope to thousands of women and families affected by this disease. https://lnkd.in/egA25rnh #worldovariancancerday #cancerresearch #ovariancancerawareness #earlydetection #cancerprevention #makecurespossible #NFCR

🌟 Behind the White Coat: Unveiling Oral Cancer – Insights from Lab to Clinic 🌟  Dive into the premiere episode of our groundbreaking podcast series, where we bridge the gap between research and real-world impact.  Join Dr. Ketki Kalele , a renowned oral histopathologist, and Mr. Swarup Sonar, a trailblazer in exosome-based cancer medicine, as they share their expertise on early detection, cutting-edge treatments, and the future of oral cancer research.  This episode is brought to you by Mun Memorial Trust, under the visionary leadership of Aniket Das, working tirelessly to raise awareness and empower lives.  🎧 Tune in to gain valuable insights, explore the latest advancements in clinical research, and join us in the fight against oral cancer. Together, let’s create a healthier tomorrow!  🔗 https://lnkd.in/gs7Me6be 💬 Don’t forget to share your thoughts, tag someone who should listen, and help spread the word about oral cancer awareness!  #OralCancer #CancerAwareness #ClinicalResearch #MunMemorialTrust #BehindTheWhiteCoat

🎗️ October is Breast Cancer Awareness Month 🎗️ As we observe this crucial month, we stand together in the fight against breast cancer, shining a light on the importance of early detection and innovative treatments. We remember Kris Helenger CoppaFeel!, whose courageous journey and advocacy for breast cancer awareness have left a lasting impact. Her legacy inspires us to continue raising awareness and supporting those affected by this disease. Thanks to the hard work of researchers and innovators, we’re witnessing incredible progress in treatment options—from personalised therapies to advanced diagnostic tools. Yet, we recognise that there’s still much more to accomplish. At Minnac Life Sciences, we are devoted to supporting those who are making a difference in the lives of individuals affected by breast cancer.  Learn more about breast cancer and the latest advancements at Cancer Research UK (CRUK) #breastcancerawarenessmonth #minnaclifesciences #cancerresearchuk

How the ICR has led the way in #OvarianCancer research 🔬 🧬 👩🔬 👨🔬 More than 300,000 women are diagnosed with ovarian cancer globally each year. Often difficult to detect in its early stages, 75 per cent of ovarian cancer cases are only discovered once the disease is advanced, when treatment options are limited and outcomes more uncertain. Despite the challenges, the ICR has been at the forefront of ovarian cancer research and drug discovery for decades. From laying the foundations for cancer research in the 1940s and becoming the first centre in Europe to develop chemotherapeutic agents in the 1950s, to the discovery of idetrexed in 2005 and the recent trials of drug combinations such as avutometinib and defactinib in 2020 – the ICR has led the way in ovarian cancer research over the course of the past century. Read more here ➡️ https://lnkd.in/eSYm_c5E Our research is helping more women survive ovarian and breast cancer. Please donate today and support the vital work our scientists are doing to defeat cancer ➡️ https://lnkd.in/egWnpnHY #TheInstituteofCancerResearch #ICR #ICRLondon #CancerTreatment #CancerResearch #DrugDiscovery #Cancer #Research

The Lung Health Foundation is proud to be one of the contributing supporters of the Canadian Cancer Society’s initiative to convene diverse experts from across Canada at a Pan-Canadian Lung Cancer Summit. This first-of-its-kind initiative will bring together lung cancer experts, thought leaders, researchers, clinicians, patient-based organizations and people with lived experience from across Canada. The summit will result in a national lung cancer action plan with defined priorities and actions to achieve our collective goal of improving Canadian lung cancer care and the lives of those affected by ensuring we are preventing, detecting and treating lung cancer in a timely and equitable way. #PanCanadianLungCancerSummit #LungCancer

June is Bowel Cancer Awareness Month. Bowel Cancer Australia's signature event to raise awareness of Australia's second deadliest cancer. Omico is currently conducting an initiative called PrOSPeCT which includes providing comprehensive genomic profiling at no cost to 23,000 Australians who have advanced or incurable cancers. If you are a patient living with advanced or incurable Bowel Cancer in Australia and you want to learn more about comprehensive genomic profiling to see how it can potentially help you, simply click here to view our patient information booklet: https://lnkd.in/g_SK5SYn Or click here to view our frequently asked questions brochure: https://lnkd.in/gkMg-H6U To learn more about PrOSPeCT and Omico, please visit: www.omico.com Help us spread awareness this June for Bowel Cancer awareness by sharing this post. #BowelCancer #BowelCancerAwarenessMonth #BowelCancerAwareness #CancerMeetsItsMatch #Omico #GenomicProfiling

”Exciting Cross-Border Collaboration on Colorectal Cancer Prevention!  We’re proud to announce that joint Danish-Swedish project “Px7” has just received a 6 million SEK grant from the Sjöberg Foundation!  This funding supports our multicentre randomized controlled trial investigating whether carrot compounds, falcarinol (FaOH) and falcarindiol (FaDOH), can prevent colorectal cancer (CRC) recurrence. With 400 patients across Denmark and Sweden, this project highlights the strength of regional teamwork in advancing cancer prevention.  A heartfelt thanks to the Sjöberg Foundation and our Danish and Swedish collaborators for making this important research possible.  Together, we aim to pave the way for innovative cancer prevention—one glass of juice at a time.  #Sahlgrenska #UniversityOfGothenburg #SATCC #CapioSanktGoranHospital #ErstaHospital #UpsalaUniversityHospital #UmeaUniversity #ColorectalCancerPrevention #carrotdiet